Rongtong Dictionary · Single Herbs

Schisandra (Wuweizi): Textual History, North versus South, Lignan Pharmacology, and the Limits of the Evidence

Published and reviewed 2026-07-08

Schisandra takes its name from 'five flavors in one fruit,' is listed in the superior class of the Shennong Bencao Jing, and is the exemplar of the astringent category. Its traditional role is to astringe and secure, boost qi and generate fluids, and tonify the kidney and calm the heart; its lignans are not only a research hotspot but gave rise to the hepatoprotective drug bifendate. Yet because it may affect drug-metabolizing enzymes, its interactions with co-administered drugs cannot be ignored.

1. Names and origins: the superior-class fruit of 'five flavors'

Schisandra enters the record in the Shennong Bencao Jing, ranked superior. Its name is distinctive — the Xinxiu Bencao, citing Su Gong, notes 'the skin and flesh are sweet-sour, the seed-kernel pungent-bitter, and all carry a salty taste, so all five flavors are present,' hence 'five-flavor fruit.' This 'five flavors in one' uniqueness was given theoretical meaning as 'the five flavors entering the five viscera.' Synonyms include xuanji and huiji (from the Bencao and Bielu).

As a chief astringent drug, schisandra is amply recorded. The Bencao Gangmu cites Sun Simiao that 'in the fifth month one often takes schisandra to tonify the qi of the five viscera,' and records its power to astringe the lung, enrich the kidney, generate fluids, check sweating, and secure essence. These traditional understandings frame schisandra's classic place in the tonifying-and-astringing system.

2. Source and authenticity: northern versus southern schisandra

The Chinese Pharmacopoeia lists two closely related but distinct items: 'schisandra' (commonly 'northern schisandra'), the dried ripe fruit of Schisandra chinensis, mainly from the northeast (Liaoning, Jilin, Heilongjiang), of good quality; and 'southern schisandra,' the fruit of Schisandra sphenanthera, mainly from central and southwestern China. Similar in action but different in source, they are listed separately, with northern schisandra the mainstream authentic drug.

The pharmacopoeia assays lignans such as schisandrol A as markers. Processing distinguishes raw from vinegar- (or wine-) processed schisandra, the former's sour-astringent nature enhanced by vinegar. The northern-versus-southern distinction is a key part of schisandra's name-and-substance, to be clarified in both purchasing and use.

3. Actions and combination: astringing and securing, boosting qi and fluids

Schisandra is sour and sweet, warm, entering the lung, heart, and kidney, classed among astringent drugs; its traditional actions are astringing and securing, boosting qi and generating fluids, and tonifying the kidney and calming the heart — astringing the lung to stop cough, securing essence and checking diarrhea, generating fluids and checking sweat, and calming the spirit. Its 'sour-astringent' and 'entering lung-heart-kidney' are functional concepts, not modern pharmacology.

In combination, schisandra's most famous use is Shengmai San — ginseng, ophiopogon, and schisandra together boost qi, nourish yin, check sweat, and generate the pulse, for qi-and-yin damage with profuse sweating and a weak pulse (a modern injection exists). It joins psoralea, nutmeg, and evodia as Sishen Wan for daybreak diarrhea, and ophiopogon and cornus to enrich kidney and secure essence. Schisandra's 'astringency' must be measured through pattern-based combination — used cautiously when an exterior pathogen is unresolved or interior excess-heat is present, lest one 'shut the door on the thief.'

4. How the physicians used it: from 'tonifying the viscera' to Zhang Xichun's rescue of collapse

Elaborations center on two words: 'astringe' and 'tonify.' Sun Simiao urged taking schisandra in summer to tonify the qi of the five viscera; Li Shizhen systematized its lung-astringing, kidney-enriching, fluid-generating, essence-securing powers and parsed the correspondence of its 'five flavors' with the five viscera. From the Jin-Yuan into the Ming-Qing, schisandra's place in 'generate the pulse' and 'stem collapse' formulas grew firmer — Shengmai San uses schisandra to astringe the dissipating lung-qi, ophiopogon to nourish yin, and ginseng to boost qi, the three mutually reinforcing, a classic for qi-and-yin deficiency with a faint pulse and profuse sweat.

The modern master Zhang Xichun especially valued schisandra's 'astringe-and-rescue-collapse' use, adding it to formulas for sinking great-qi and wheezing collapse for its sour-astringent securing force. Zhang also warned that schisandra's 'astringing power is very great,' so in externally contracted cough it must await release of the exterior, lest it 'trap the pathogen.' This dialectic — valuing its astringency yet wary of its trapping — embodies traditional 'treat the pattern, not universally' wisdom, echoing across time the modern double recognition that schisandra is both a hepatoprotection research hotspot and a source of drug interactions.

5. Chemistry and pharmacology: lignans and the modern legend of bifendate

Schisandra's signature compounds are dibenzocyclooctadiene lignans (schisandrol A/B, schisandrin A/B/C, and others) and volatile oil. The lignans are the most-studied class, with preclinical work suggesting hepatoprotective (lowering transaminases, antioxidant, modulating pathways such as Nrf2), sedative, and adaptogen-like activities.

Schisandra's most striking modern story is that it gave rise to a marketed pharmaceutical: while studying schisandra's transaminase-lowering effect, researchers used its lignan (schisandrin C) as a lead to synthesize bifendate (DDB), used for raised transaminases in chronic hepatitis — a classic 'from herb to chemical drug' case. But it must be stressed: a single-compound derivative's efficacy cannot be run backward into 'eating schisandra protects the liver'; the sliced drug, the extract, and bifendate are three different things whose human evidence must be assessed separately, and most traditional claims still lack high-quality clinical confirmation.

6. From sliced drug to product: schisandra, lignan extract, and bifendate

Schisandra's product spectrum is instructive. Traditionally, northern and southern schisandra and vinegar-processed forms enter Shengmai San, Sishen Wan, and countless formulas; in modern practice, schisandra extract (standardized to lignans) serves as a supplement, while bifendate, derived from schisandra lignan research, is a formal chemical drug for lowering transaminases.

Three boundaries: northern and southern schisandra differ in source, so their composition and research are not interchangeable; schisandra sliced drug/extract (supplement context) and bifendate (prescription-drug context) are utterly different, and their evidence must not be conflated; and as a 'hepatoprotection' hotspot, schisandra has abundant mechanistic research, but equating 'a compound lowers transaminases' with 'oral schisandra treats liver disease' is a dangerous leap. The three evidence streams must not be conflated.

7. Dose, processing, and pharmacopoeial use (for professional reference)

The Chinese Pharmacopoeia gives a usual decoction dose of 2–6 g. Raw and vinegar-processed schisandra differ in emphasis (vinegar enhances sour astringency), and the choice follows treatment strategy. Schisandra's astringing force is considerable, so it should be used cautiously or avoided when an exterior pattern is unresolved, interior excess-heat is present, or a cough is newly arising, lest it trap the pathogen. The dose range is given to explain the standard, not as individualized advice; people on hepatically metabolized drugs should consult a professional before using schisandra extract.

8. Safety boundaries and interactions

As a drug at standard doses schisandra is generally well tolerated, but its lignans may affect drug-metabolizing enzymes (e.g., CYP3A4) and transporters (e.g., P-glycoprotein), altering blood levels of some co-administered drugs (e.g., immunosuppressants like tacrolimus, and some CYP3A4-metabolized drugs) — interactions that cannot be ignored. People on polypharmacy, post-transplant medication, or narrow-therapeutic-window drugs must consult a clinician before using schisandra (especially extracts). It should also be used cautiously with unresolved exterior patterns and excess-heat, and in some populations. Stop and seek care for abnormal reactions, and disclose schisandra and its products alongside other drugs at clinical visits.

9. How to judge whether a claim about schisandra is credible

• Does it distinguish northern schisandra — southern schisandra — lignan extract — bifendate (a drug)?
• Does it separate traditional astringing and hepatoprotective/mechanistic claims from modern human clinical evidence?
• Does it state whether studies are in vitro/animal or human, with type, comparator, sample size, and limits?
• Does it avoid leaping promises like 'eating schisandra = liver protection, cures all'?
• Does it flag CYP450/P-glycoprotein drug interactions and cautions like avoiding use with unresolved exterior patterns?

Educational content only. It does not provide a diagnosis, prescription, or individualized treatment recommendation. The pharmacopoeial dose range is given to explain the standard, not as a basis for self-medication. Seek qualified care for persistent or urgent symptoms.